SCHEMBL19968187

SCHEMBL19968187

Cc1c(-c2ccc(C(C)(C)C)cc2)ccc(N)c1C=N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 6/20 0.40
▸ RAB9A P51151 6/20 0.40
▸ TP53 P04637 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ DGAT1 O75907 2/20 0.39
▸ S1PR1 P21453 1/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ MAPT P10636 3/20 0.35
▸ HPGD P15428 2/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ TSHR P16473 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ KIF11 P52732 3/20 0.33
▸ IKBKB O14920 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ MITF O75030 1/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5058981 0.72 NPC1 (0.42) NPC1RAB9ATP53SMN1; SMN2LMNA
SCHEMBL25455048 0.69 MAP4K4 (0.43) NPC1RAB9ASMN1; SMN2ALDH1A1TSHR
SCHEMBL23432313 0.69 NPC1 (0.49) NPC1RAB9ATP53SMN1; SMN2LMNA
SCHEMBL24174951 0.68 TSHR (0.50) NPC1RAB9ATP53SMN1; SMN2LMNA
SCHEMBL24522126 0.68 TSHR (0.48) NPC1RAB9ATP53SMN1; SMN2LMNA
SCHEMBL22600547 0.68 CYP3A4 (0.34) TP53SMN1; SMN2ALDH1A1TSHR
SCHEMBL23406367 0.67 NPC1 (0.44) NPC1RAB9ATP53SMN1; SMN2LMNA
SCHEMBL6573941 0.66 RAB9A (0.46) NPC1RAB9ATP53SMN1; SMN2LMNA
SCHEMBL22969925 0.66 FFAR4 (0.35) SMN1; SMN2TSHRKIF11GAA
SCHEMBL25955331 0.66 ALDH1A1 (0.30) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018048762-A1 INDAZOLE DERIVATIVES USEFUL AS GLUCAGON RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2018-03-15 — — WO disclosed
Send feedback